EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 231 filers reported holding EDITAS MEDICINE INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86,627 | -5.4% | 11,106 | -0.2% | 0.02% | +5.9% |
Q2 2023 | $91,592 | +47.7% | 11,129 | +113.2% | 0.02% | +30.8% |
Q2 2022 | $62,000 | -55.4% | 5,220 | -28.8% | 0.01% | -48.0% |
Q1 2022 | $139,000 | -35.3% | 7,330 | -9.6% | 0.02% | -30.6% |
Q4 2021 | $215,000 | -28.8% | 8,108 | +10.2% | 0.04% | -33.3% |
Q3 2021 | $302,000 | -31.5% | 7,360 | -5.5% | 0.05% | -33.3% |
Q2 2021 | $441,000 | +62.1% | 7,786 | +20.3% | 0.08% | +30.6% |
Q1 2021 | $272,000 | -31.7% | 6,471 | +14.0% | 0.06% | -38.0% |
Q4 2020 | $398,000 | +60.5% | 5,678 | -35.8% | 0.10% | +23.5% |
Q3 2020 | $248,000 | +100.0% | 8,838 | +111.0% | 0.08% | +72.3% |
Q2 2020 | $124,000 | -21.0% | 4,188 | -47.2% | 0.05% | -34.7% |
Q1 2020 | $157,000 | -1.9% | 7,932 | +47.1% | 0.07% | +20.0% |
Q4 2019 | $160,000 | +92.8% | 5,393 | +48.6% | 0.06% | +62.2% |
Q3 2019 | $83,000 | -67.1% | 3,629 | -65.6% | 0.04% | -66.1% |
Q2 2019 | $252,000 | -11.6% | 10,544 | -9.6% | 0.11% | -25.3% |
Q1 2019 | $285,000 | -9.5% | 11,659 | -15.7% | 0.15% | -29.5% |
Q4 2018 | $315,000 | -20.9% | 13,825 | +10.6% | 0.21% | -13.0% |
Q3 2018 | $398,000 | -8.3% | 12,503 | +3.1% | 0.24% | -48.7% |
Q2 2018 | $434,000 | – | 12,125 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |